Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Alloy vs Get Thin MD

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.4

Alloy

Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory
★★★3.7

Starting at $80/mo

Brand WegovyBrand ZepboundCompounded SemaglutideCompounded Tirzepatide
Visit Alloy
7.9

Get Thin MD

Best for lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available
★★★★4

Starting at $169/mo

CompoundedSemaglutideTirzepatideBrand
Visit Get Thin MD

Side-by-Side Comparison

FeatureAlloyGet Thin MD
Overall Score7.4/107.9/10
Starting Price$80/mo$169/mo
Editorial Rating3.7 ★ /54 ★ /5
Features8 features7 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Alloy

Pros

  • Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
  • All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
  • Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
  • STARTGLP1 promo code knocks $50 off the first month per the public site

Cons

  • Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
  • Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
  • Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss

Get Thin MD

Pros

  • 3-month compounded semaglutide plan at $169/month is one of the lowest ongoing prices in the compounded GLP-1 category
  • Price-lock positioning: 'Same price, every dose. No hidden fees.' — per the product page
  • Both compounded and brand-name options available in one platform (compounded semaglutide, compounded tirzepatide, plus brand-name Ozempic and Zepbound where medically appropriate)
  • Nationwide availability with async evaluation — no in-person visit required
  • Broader wellness platform that also offers sermorelin, NAD+, HRT, and hair-loss treatments, so patients can consolidate multiple protocols with one provider
  • Proper FDA compounding disclaimer on the product page: "The FDA does not review or approve any compounded medications for safety or effectiveness."

Cons

  • Compounded medications are not FDA-approved as finished products and lack the formal safety/efficacy review of brand-name Ozempic, Wegovy, Zepbound, and Mounjaro
  • Pharmacy partners not publicly named on the site — no independent way to verify 503A/503B compounding source or per-batch testing
  • State-by-state availability claimed as nationwide but no verbatim state list is published — needs intake signup to confirm whether every state is actually served
  • Clinical efficacy headline ("9.6 pounds in 30 days") is based on 645 self-reported patient data points from Jan 2024 – Apr 2025 — self-reported data is lower-quality than a randomized trial
  • Broader wellness funnel (sermorelin + NAD+ + HRT alongside GLP-1s) means some patients may be upsold into off-weight-loss protocols — readers looking specifically for GLP-1 care should know the platform has a wider vertical mix

Our Verdict

Winner: Get Thin MDScore: 7.9/10

Get Thin MD edges out Alloy with a higher overall score of 7.9/10 and is particularly strong for lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available. Alloy remains a solid alternative, especially if you're looking for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.